Posatirelin
CAS: 78664-73-0
Ref. 3D-DDA66473
1mg | 338.00 € | ||
5mg | 716.00 € | ||
10mg | 1,077.00 € | ||
25mg | 2,020.00 € | ||
50mg | 3,231.00 € |
Product Information
- (-)-(2S)-N-(1S)-1-((2S)-2-Carbamoyl-1-pyrrolidinyl)carbonyl-3-(methylbutyl)-6-oxopipecolamide
- (2S)-6-Oxo-2-piperidinecarbonyl-<span class="text-smallcaps">L</smallcap>-leucyl-<smallcap>L</span>-prolinamide
- (S)-L-Leucyl-N-((6-oxo-2-piperidinyl)carbonyl)-L-prolinamide
- <span class="text-smallcaps">L</smallcap>-6-Ketopiperidine-2-carbonyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</span>-proline amide
- <span class="text-smallcaps">L</smallcap>-Prolinamide, (2S)-6-oxo-2-piperidinecarbonyl-<smallcap>L</span>-leucyl-
- <span class="text-smallcaps">L</smallcap>-Prolinamide, N-[(6-oxo-2-piperidinyl)carbonyl]-<smallcap>L</span>-leucyl-, (S)-
- Brn 6006446
- L-6-Ketopiperidine-2-carbonyl-leucyl-L-prolin-amide
- L-Prolinamide, N-((6-oxo-2-piperidinyl)carbonyl)-L-leucyl-, (S)-
- L-Pyro-2-aminoadipyl-L-leucyl-L-prolinamide
- See more synonyms
- N-{[(2S)-6-oxopiperidin-2-yl]carbonyl}-L-leucyl-L-prolinamide
- Posatirelin [INN]
- Posatirelina
- Posatirelina [INN-Spanish]
- Posatireline
- Posatireline [INN-French]
- Posatirelinum
- Posatirelinum [INN-Latin]
- Rgh-2202
- Unii-78U6302Arl
Posatirelin is a drug that is used to treat the symptoms of Parkinson's disease, including motor and non-motor symptoms. It has been shown to be effective in improving motor skills, reducing tremors and stiffness, improving speech and cognitive function, and increasing energy levels. This drug is administered as an injection into the muscle or under the skin. The most common side effects are pain at the site of injection, headache, dizziness, nausea, vomiting and sleepiness. Posatirelin is metabolized by cytochrome P450 enzymes in the liver and excreted in urine as metabolites. It should not be taken with other drugs that induce these enzymes such as carbamazepine or phenytoin because this will increase posatirelin blood levels and lead to toxicity. Posatirelin does not interact with any drugs currently on the market for Parkinson's disease treatment; however it may interact with some other drugs that are not on the market for this purpose. The
Chemical properties
Technical inquiry about: 3D-DDA66473 Posatirelin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.